• Follow
  • Follow
  • Follow
  • Follow
  • Platform
  • Solutions
    • AlertWatch:OR
    • AlertWatch:OB
    • AlertWatch:AC
  • Research
  • About
    • Blog
  • Try the Demo
  • Contact

AlertWatch gains FDA clearance to sell its new mobile application

by alertwatch-admin | Mar 22, 2016 | Uncategorized

FOR IMMEDIATE RELEASE–March 22, 2016, Ann Arbor, MI–AlertWatch gains FDA clearance to sell its new mobile application AlertWatch recently received FDA clearance for a brand new version of its patient monitoring software. The new version has hundreds of new features,...

Dr. Jim Bagian – A Leader in Patient Safety

by alertwatch-admin | Apr 29, 2015 | Uncategorized

The entire team at AlertWatch is proud that one of our co-founders, Dr. Jim Bagian, has been chosen as a leader in the field of patient safety.http://www.beckershospitalreview.com/lists/50-experts-leading-the-field-of-patient-safety-2015.html
Next Entries »

Recent Posts

  • Welcome to the new AlertWatch website! July 30, 2021
  • Clinical Computer Systems, Inc. announces a reseller agreement with AlertWatch December 26, 2020
  • Anesthesia Staffing Shortage – Winter is Coming November 20, 2019
  • Joint Commission urges action on maternal safety September 11, 2019
  • AlertWatch announces strategic relationship with Qualcomm Life February 28, 2018

PLATFORM
RESEARCH
ABOUT
BLOG

CONTACT
DEMO
SERVICE LEVELS

  • Follow
  • Follow
  • Follow
  • Follow

AlertWatch:OR
AlertWatch:OB
AlertWatch:AC

AlertWatch:OR, AlertWatch:AC and AlertWatch:OB are FDA 510(k)-cleared for sale in the United States, andare intended for use by clinicians for secondary monitoring of patients. AlertWatch accomplishes this by aggregating data from a multitude of sources and displaying them at a central location. Once alerted, the clinician must refer to the primary monitoring device before making a clinical decision.

© Copyright 2021 AlertWatch. All rights reserved.